A new scientific publication referencing glucagon-like peptide biology relevant to teduglutide was published on October 20, 2026. The paper, titled "Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury," appeared in the journal Cell Reports Medicine. Teduglutide is an approved compound, and this publication adds to the scientific literature in this area. The publication is indexed under PubMed ID 42901164. No specific findings, outcomes, or conclusions from the study are detailed here beyond its title and publication venue. Readers interested in the underlying science should consult the original article directly for full methodology and results. This brief reports only that the publication occurred and where it appeared. For additional context on teduglutide, including its approved uses and background, readers can consult the compound overview.
Teduglutide-Related Study on Gut Glucagon-like Peptides Published in Cell Reports Medicine
See the full teduglutide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42901164/